1. Home
  2. IRD vs HCWC Comparison

IRD vs HCWC Comparison

Compare IRD & HCWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • HCWC
  • Stock Information
  • Founded
  • IRD 2018
  • HCWC N/A
  • Country
  • IRD United States
  • HCWC
  • Employees
  • IRD N/A
  • HCWC 450
  • Industry
  • IRD
  • HCWC
  • Sector
  • IRD
  • HCWC
  • Exchange
  • IRD NYSE
  • HCWC NYSE
  • Market Cap
  • IRD 62.0M
  • HCWC 5.0M
  • IPO Year
  • IRD N/A
  • HCWC N/A
  • Fundamental
  • Price
  • IRD $1.02
  • HCWC $0.44
  • Analyst Decision
  • IRD Strong Buy
  • HCWC
  • Analyst Count
  • IRD 3
  • HCWC 0
  • Target Price
  • IRD $6.33
  • HCWC N/A
  • AVG Volume (30 Days)
  • IRD 803.8K
  • HCWC N/A
  • Earning Date
  • IRD 08-15-2025
  • HCWC N/A
  • Dividend Yield
  • IRD N/A
  • HCWC N/A
  • EPS Growth
  • IRD N/A
  • HCWC N/A
  • EPS
  • IRD N/A
  • HCWC N/A
  • Revenue
  • IRD $13,651,000.00
  • HCWC N/A
  • Revenue This Year
  • IRD $51.41
  • HCWC N/A
  • Revenue Next Year
  • IRD $68.84
  • HCWC N/A
  • P/E Ratio
  • IRD N/A
  • HCWC N/A
  • Revenue Growth
  • IRD N/A
  • HCWC N/A
  • 52 Week Low
  • IRD $0.65
  • HCWC N/A
  • 52 Week High
  • IRD $2.18
  • HCWC N/A
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • HCWC N/A
  • Support Level
  • IRD N/A
  • HCWC N/A
  • Resistance Level
  • IRD N/A
  • HCWC N/A
  • Average True Range (ATR)
  • IRD 0.00
  • HCWC 0.00
  • MACD
  • IRD 0.00
  • HCWC 0.00
  • Stochastic Oscillator
  • IRD 0.00
  • HCWC 0.00

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About HCWC HEALTHY CHOICE WELLNESS CORP

Healthy Choice Wellness Corp is a company engaged in providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The company has one reportable segment which is natural and organic retail stores.

Share on Social Networks: